Exponent PE Ratio 2011-2025 | EXPO
Current and historical p/e ratio for Exponent (EXPO) from 2011 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Exponent PE ratio as of November 14, 2025 is 34.11.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Exponent PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-11-14 | 69.94 | 46.63 | |
| 2025-09-30 | 69.48 | $1.50 | 46.32 |
| 2025-06-30 | 74.40 | $2.00 | 37.20 |
| 2025-03-31 | 80.41 | $2.05 | 39.23 |
| 2024-12-31 | 88.07 | $2.12 | 41.54 |
| 2024-09-30 | 113.61 | $2.07 | 54.89 |
| 2024-06-30 | 93.50 | $2.05 | 45.61 |
| 2024-03-31 | 81.04 | $1.98 | 40.93 |
| 2023-12-31 | 85.98 | $1.95 | 44.09 |
| 2023-09-30 | 83.34 | $1.98 | 42.09 |
| 2023-06-30 | 90.59 | $1.97 | 45.98 |
| 2023-03-31 | 96.51 | $1.96 | 49.24 |
| 2022-12-31 | 95.69 | $1.96 | 48.82 |
| 2022-09-30 | 84.46 | $1.90 | 44.45 |
| 2022-06-30 | 87.90 | $1.89 | 46.51 |
| 2022-03-31 | 103.56 | $1.88 | 55.08 |
| 2021-12-31 | 111.60 | $1.90 | 58.73 |
| 2021-09-30 | 107.98 | $1.93 | 55.95 |
| 2021-06-30 | 84.99 | $1.81 | 46.95 |
| 2021-03-31 | 92.63 | $1.64 | 56.48 |
| 2020-12-31 | 85.40 | $1.55 | 55.10 |
| 2020-09-30 | 68.17 | $1.50 | 45.45 |
| 2020-06-30 | 76.40 | $1.52 | 50.26 |
| 2020-03-31 | 67.72 | $1.60 | 42.33 |
| 2019-12-31 | 64.83 | $1.53 | 42.37 |
| 2019-09-30 | 65.50 | $1.47 | 44.56 |
| 2019-06-30 | 54.73 | $1.43 | 38.27 |
| 2019-03-31 | 53.82 | $1.38 | 39.00 |
| 2018-12-31 | 47.14 | $1.34 | 35.31 |
| 2018-09-30 | 49.70 | $0.97 | 51.50 |
| 2018-06-30 | 44.67 | $0.92 | 48.82 |
| 2018-03-31 | 36.28 | $0.83 | 43.71 |
| 2017-12-31 | 32.69 | $0.76 | 43.01 |
| 2017-09-30 | 33.88 | $1.03 | 33.06 |
| 2017-06-30 | 26.65 | $0.97 | 27.61 |
| 2017-03-31 | 27.12 | $0.90 | 30.14 |
| 2016-12-31 | 27.36 | $0.88 | 31.27 |
| 2016-09-30 | 23.10 | $0.86 | 26.86 |
| 2016-06-30 | 26.34 | $0.87 | 30.45 |
| 2016-03-31 | 22.92 | $0.89 | 25.76 |
| 2015-12-31 | 22.36 | $0.80 | 28.04 |
| 2015-09-30 | 19.89 | $0.79 | 25.26 |
| 2015-06-30 | 19.92 | $0.77 | 25.79 |
| 2015-03-31 | 19.70 | $0.76 | 25.93 |
| 2014-12-31 | 18.22 | $0.74 | 24.71 |
| 2014-09-30 | 15.61 | $0.73 | 21.52 |
| 2014-06-30 | 16.26 | $0.72 | 22.51 |
| 2014-03-31 | 16.41 | $0.71 | 23.03 |
| 2013-12-31 | 16.84 | $0.69 | 24.49 |
| 2013-09-30 | 15.63 | $0.68 | 22.98 |
| 2013-06-30 | 12.83 | $0.66 | 19.36 |
| 2013-03-31 | 11.67 | $0.65 | 17.96 |
| 2012-12-31 | 12.05 | $0.65 | 18.46 |
| 2012-09-30 | 12.32 | $0.64 | 19.33 |
| 2012-06-30 | 11.40 | $0.61 | 18.77 |
| 2012-03-31 | 10.47 | $0.57 | 18.53 |
| 2011-12-31 | 9.92 | $0.56 | 17.87 |
| 2011-09-30 | 8.92 | $0.52 | 17.07 |
| 2011-06-30 | 9.39 | $0.50 | 18.69 |
| 2011-03-31 | 9.63 | $0.49 | 19.85 |
| 2010-12-31 | 8.10 | $0.46 | 17.71 |
| 2010-09-30 | 7.25 | $0.43 | 16.86 |
| 2010-06-30 | 7.06 | $0.40 | 17.76 |
| 2010-03-31 | 6.15 | $0.38 | 16.30 |
| 2009-12-31 | 6.01 | $0.37 | 16.35 |
| 2009-09-30 | 6.08 | $0.38 | 16.10 |
| 2009-06-30 | 5.29 | $0.38 | 14.10 |
| 2009-03-31 | 5.47 | $0.37 | 14.98 |
| 2008-12-31 | 6.49 | $0.37 | 17.54 |
| 2008-09-30 | 7.14 | $0.37 | 19.43 |
| 2008-06-30 | 6.78 | $0.35 | 19.37 |
| 2008-03-31 | 7.09 | $0.34 | 21.15 |
| 2007-12-31 | 5.84 | $0.31 | 18.67 |
| 2007-09-30 | 5.41 | $0.28 | 19.69 |
| 2007-06-30 | 4.83 | $0.25 | 19.12 |
| 2007-03-31 | 4.31 | $0.23 | 18.72 |
| 2006-12-31 | 4.03 | $0.21 | 19.52 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Business Services | Consulting Services | $3.489B | $0.559B |
| Exponent, Inc., is a multidisciplinary organization of scientists, physicians, engineers and business consultants performing in-depth scientific research and analysis in over 90 technical disciplines. The company is an engineering and scientific consulting firm providing solutions to complex problems. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future. The Company serves clients in the automotive, aviation, chemical, construction, consumer products, energy, government, health, insurance, manufacturing, technology and other sectors. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Equifax (EFX) | United States | $25.336B | 26.92 |
| Gartner (IT) | United States | $16.590B | 15.64 |
| Bureau Veritas Registre De Classification (BVRDF) | France | $15.054B | 0.00 |
| Stantec (STN) | Canada | $11.945B | 28.38 |
| Booz Allen Hamilton Holding (BAH) | United States | $10.215B | 13.74 |
| FTI Consulting (FCN) | United States | $5.093B | 19.23 |
| CBIZ (CBZ) | United States | $2.829B | 12.84 |
| Huron Consulting Group (HURN) | United States | $2.789B | 21.37 |
| Charles River Associates (CRAI) | United States | $1.191B | 22.15 |
| PAGEGROUP (MPGPF) | United Kingdom | $1.058B | 0.00 |
| Hackett (HCKT) | United States | $0.497B | 19.91 |
| Information Services (III) | United States | $0.251B | 29.17 |
| Franklin Covey (FC) | United States | $0.183B | 28.47 |
| Accos (ACCL) | Hong Kong, SAR China | $0.058B | 0.00 |
| ATIF Holdings (ZBAI) | China | $0.007B | 0.00 |